Phreesia, Inc. (NYSE:PHR) COO Sells $105,781.14 in Stock

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 3,519 shares of the business’s stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $30.06, for a total value of $105,781.14. Following the completion of the sale, the chief operating officer now owns 741,197 shares in the company, valued at $22,280,381.82. This represents a 0.47 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Evan Roberts also recently made the following trade(s):

• On Thursday, February 13th, Evan Roberts sold 16,005 shares of Phreesia stock. The stock was sold at an average price of $30.00, for a total value of $480,150.00.
• On Monday, January 27th, Evan Roberts sold 10,716 shares of Phreesia stock. The stock was sold at an average price of $27.48, for a total value of $294,475.68.
• On Tuesday, January 21st, Evan Roberts sold 12,749 shares of Phreesia stock. The stock was sold at an average price of $27.31, for a total value of $348,175.19.
• On Wednesday, January 15th, Evan Roberts sold 1,785 shares of Phreesia stock. The stock was sold at an average price of $26.98, for a total value of $48,159.30.
• On Wednesday, January 8th, Evan Roberts sold 2,681 shares of Phreesia stock. The stock was sold at an average price of $27.95, for a total value of $74,933.95.
• On Monday, January 6th, Evan Roberts sold 2,873 shares of Phreesia stock. The stock was sold at an average price of $26.61, for a total value of $76,450.53.

Phreesia Stock Down 0.9 %

Shares of NYSE:PHR opened at $28.20 on Friday. Phreesia, Inc. has a 52-week low of $17.07 and a 52-week high of $30.53. The stock has a market cap of $1.64 billion, a P/E ratio of -19.18 and a beta of 0.96. The business’s 50 day moving average is $27.29 and its 200 day moving average is $23.84. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04.

Phreesia (NYSE:PHR) last announced its quarterly earnings data on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The company had revenue of $106.80 million for the quarter, compared to analysts’ expectations of $106.33 million. During the same quarter in the prior year, the firm earned ($0.58) earnings per share. Phreesia’s revenue was up 16.6% compared to the same quarter last year. Sell-side analysts predict that Phreesia, Inc. will post -1.1 EPS for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on PHR shares. Citigroup boosted their price objective on Phreesia from $31.00 to $35.00 and gave the stock a “buy” rating in a research note on Friday, January 10th. KeyCorp boosted their price objective on Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 8th. Needham & Company LLC reissued a “buy” rating and set a $29.00 price objective on shares of Phreesia in a research note on Friday, January 10th. Royal Bank of Canada raised Phreesia from a “sector perform” rating to an “outperform” rating and boosted their price objective for the stock from $24.00 to $32.00 in a research note on Wednesday, January 8th. Finally, Truist Financial upped their target price on Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. Thirteen analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $31.15.

Institutional Trading of Phreesia

A number of hedge funds have recently bought and sold shares of PHR. Johnson Financial Group Inc. lifted its holdings in Phreesia by 381.3% during the fourth quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company’s stock worth $28,000 after buying an additional 896 shares during the period. R Squared Ltd purchased a new stake in Phreesia during the fourth quarter worth $30,000. International Assets Investment Management LLC lifted its holdings in Phreesia by 2,179.7% during the third quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock worth $33,000 after buying an additional 1,395 shares during the period. BankPlus Trust Department purchased a new stake in Phreesia during the fourth quarter worth $34,000. Finally, Quarry LP lifted its holdings in Phreesia by 210.9% during the fourth quarter. Quarry LP now owns 2,835 shares of the company’s stock worth $71,000 after buying an additional 1,923 shares during the period. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.